Qualigen Therapeutics Quote - QLGN

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

4.28

Bid

4.01

Offer

4.19

Volume

21,004

3.90 Day's Range 4.31

3.3358 52 Week Range 29.435

Market Cap

3.152M

Previous Close

4.17

Open

4.20

Last Trade

4.02

Last Trade Time

Financial Volume

US$ 86,317

VWAP

4.1096

Average Volume (3m)

3,053,073

Shares Outstanding

736,431

Dividend Yield

PE Ratio

-0.02

Earnings Per Share (EPS)

-18.22

Revenue

Net Profit

-13.42M

Qualigen Therapeutics Inc is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases using nanoparticle coating technology. Qualigen Therapeutics Inc is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases using nanoparticle coating technology.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.qualigeninc.com

Headquarters

Wilmington, Delaware, USA

Founded

Qualigen Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker QLGN. The last closing price for Qualigen Therapeutics was US$4.17. Over the last year, Qualigen Therapeutics shares have traded in a share price range of US$ 3.3358 to US$ 29.435.

Qualigen Therapeutics currently has 736,431 shares in issue. The market capitalisation of Qualigen Therapeutics is US$3.07 million. Qualigen Therapeutics has a price to earnings ratio (PE ratio) of -0.02.

Form 8-K - Current report

Form EFFECT - Notice of Effectiveness

Form S-1 - General form for registration of securities under the Securities Act of 1933

Qualigen Therapeutics Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement and the Equity Requirement

Carlsbad, CA, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics (NASDAQ: QLGN) (the “Company” or “Qualigen”) today announced that the Company received formal notice from The Nasdaq Stock...

Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN)

New York, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.06	1.42180094787	4.22	4.67	4.15	25971	4.4437219	CS
4	0.48	12.6315789474	3.8	4.67	3.53	28628	4.24406142	CS
12	-3.595	-45.6507936508	7.875	10.45	3.3358	3053073	5.73796191	CS
26	-6.14	-58.9251439539	10.42	29.435	3.3358	5064969	16.80418634	CS
52	-22.94	-84.2762674504	27.22	29.435	3.3358	3946380	15.52171132	CS
156	-510.72	-99.1689320388	515	760	3.3358	1505384	52.62949322	CS
260	-3620.72	-99.8819310345	3625	3950	3.3358	1791348	659.75962146	CS

QLGN - Frequently Asked Questions (FAQ)

What is the current Qualigen Therapeutics share price?

The current share price of Qualigen Therapeutics is US$ 4.28

How many Qualigen Therapeutics shares are in issue?

Qualigen Therapeutics has 736,431 shares in issue

What is the market cap of Qualigen Therapeutics?

The market capitalisation of Qualigen Therapeutics is USD 3.07M

What is the 1 year trading range for Qualigen Therapeutics share price?

Qualigen Therapeutics has traded in the range of US$ 3.3358 to US$ 29.435 during the past year

What is the PE ratio of Qualigen Therapeutics?

The price to earnings ratio of Qualigen Therapeutics is -0.02

What is the reporting currency for Qualigen Therapeutics?

Qualigen Therapeutics reports financial results in USD

What is the latest annual profit for Qualigen Therapeutics?

The latest annual profit of Qualigen Therapeutics is USD -13.42M

What is the registered address of Qualigen Therapeutics?

The registered address for Qualigen Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Qualigen Therapeutics website address?

The website address for Qualigen Therapeutics is www.qualigeninc.com

Which industry sector does Qualigen Therapeutics operate in?

Qualigen Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
VRMEVerifyMe Inc	US$ 2.57 (52.98%)	57.83M
WKEYWISeKey International Holdings AG	US$ 10.041 (52.83%)	6.72M
DATSDatChat Inc	US$ 4.8105 (49.86%)	158.63M
CDTConduit Pharmaceuticals Inc	US$ 0.1214 (48.05%)	1.17B
INTZIntrusion Inc	US$ 2.8888 (44.44%)	40.61M
IGMSIGM Biosciences Inc	US$ 2.095 (-66.21%)	5.81M
CDTGCDT Environmental Technology Investment Holdings Ltd	US$ 1.87 (-51.30%)	2.28M
MODVModivCare Inc	US$ 6.51 (-47.88%)	2.73M
AIFUAIX Inc	US$ 0.420501 (-47.76%)	7.85M
MRSNMersana Therapeutics Inc	US$ 0.691 (-46.85%)	58.44M
CDTConduit Pharmaceuticals Inc	US$ 0.1214 (48.05%)	1.17B
NVDANVIDIA Corporation	US$ 135.91 (-3.00%)	207.51M
RGTIRigetti Computing Inc	US$ 8.9299 (-11.06%)	178.77M
VMARVision Marine Technologies Inc	US$ 2.14 (40.79%)	175.57M
DATSDatChat Inc	US$ 4.8105 (49.86%)	158.63M